Philip Stephen Wells
Philip Stephen Wells publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #142,410 of 7,710,434 ranked researchers
- Rank in Canada
- #4,652 of 183,316
- Works
- 422
- Citations
- 31k
- Citations per work
- 74.4
What does Philip Stephen Wells research?
Philip Stephen Wells's work is mostly in Medicine (72%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences32276.2%
- Medicine30672.5%
- Health Professions163.7%
- Everything else10023.8%
- 1Internal Medicine29% of their works
- 2Cardiology and Cardiovascular Medicine22% of their works
- 3Surgery10% of their works
- 4Hematology10% of their works
- 5Emergency Medical Services4% of their works
- 6Epidemiology3% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Central Venous Catheters and Hemodialysis
- Diagnosis and Treatment of Venous Diseases
- Acute Ischemic Stroke Management
- Acute Myocardial Infarction Research
Which keywords describe Philip Stephen Wells's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Clinical Practice Guidelines, Risk Factors, Pulmonary Embolism, Venous Thromboembolism, Guidelines and Anticoagulant Therapy.
- Acute Coronary Syndromes
- Ischemic Stroke
- Chronic Venous Insufficiency
- Catheter-Related Infections
- Heparin-Induced Thrombocytopenia
- Protease-Activated Receptors
- Anticoagulant Therapy
- Venous Thromboembolism
- Risk Factors
- Diagnosis
- Antithrombotic Therapy
- Clinical Practice Guidelines
- Pulmonary Embolism
- Guidelines
- Atrial Fibrillation
- Thrombin
- Thrombosis
- Central Venous Catheterization
- Varicose Veins
- Thrombolysis
- Myocardial Infarction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antithrombotic Therapy4232 topics
- Diagnosis3772 topics
- Clinical Practice Guidelines3722 topics
- Risk Factors3552 topics
- Pulmonary Embolism3301 topic
- Venous Thromboembolism3301 topic
- Guidelines1952 topics
- Anticoagulant Therapy1711 topic
- Atrial Fibrillation1711 topic
- Protease-Activated Receptors931 topic
- Thrombin931 topic
- Heparin-Induced Thrombocytopenia471 topic
- Thrombosis471 topic
- Catheter-Related Infections421 topic
- Central Venous Catheterization421 topic
- Chronic Venous Insufficiency421 topic
- Varicose Veins421 topic
- Ischemic Stroke251 topic
- Thrombolysis251 topic
- Acute Coronary Syndromes241 topic
- Myocardial Infarction241 topic
Where does Philip Stephen Wells work?
Philip Stephen Wells's main affiliation in the publication record is University of Ottawa, Canada.
How many publications and citations does Philip Stephen Wells have?
OpenAlex counts 422 works and 31,378 citations for Philip Stephen Wells, an h-index of 78, ranking #142,410 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Philip Stephen Wells. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.